Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 23, 2015 12:36 PM ET


Company Overview of River Vision Development Corp.

Company Overview

River Vision Development Corp. develops RV001, a protein therapy for the treatment of Graves’ Orbitopathy (GO). The company was founded in 2011 and is based in New York, New York.

One Rockefeller Plaza

Suite 1204

New York, NY 10020

United States

Founded in 2011



Key Executives for River Vision Development Corp.

Chief Executive Officer and Director
Age: 51
Compensation as of Fiscal Year 2014.

River Vision Development Corp. Key Developments

River Vision Development Corp. Announces Receipt of Orphan Drug Designation

River Vision Development Corp. announced that RV001, the company's human monoclonal antibody teprotumumab, has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of active phase Graves Orbitopathy (GO), also known as Thyroid Eye Disease. GO is a condition afflicting a proportion of Graves' Disease patients, in which an autoimmune response is mounted against tissues behind the eye, causing inflammation, tissue proliferation and excess production of extracellular matrix. The resulting excess tissue in the area behind the eye causes the eyeballs to protrude from the socket, often resulting in serious ocular morbidity and highly distressing changes in the patient's appearance.

Similar Private Companies By Industry

Company Name Region
Genomics USA, Inc. United States
Paracelsian Inc. United States
Tamir Biotechnology, Inc. United States
Enobia Canada Limited Partnership United States
Tinea Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Private Placement
January 28, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact River Vision Development Corp., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at